Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
219
datasets available to search
ShareScore release 0.9.0
Dataset results
219 results for “epic”
Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes
ClinicalTrials.gov study NCT05389631. IPD Sharing: Not stated. Countries: 3. Publications: 1.
EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial
ClinicalTrials.gov study NCT00233038. IPD Sharing: Not stated. Countries: 1. Publications: 2.
EPIC WheelS Feasibility Study
ClinicalTrials.gov study NCT01740635. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)
ClinicalTrials.gov study NCT06840860. IPD Sharing: NO. Countries: 1. Publications: 1.
EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine)
ClinicalTrials.gov study NCT00335582. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Enhancing PrEP in Community Settings (EPIC)
ClinicalTrials.gov study NCT02371525. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions
ClinicalTrials.gov study NCT04306172. IPD Sharing: NO. Countries: 1. Publications: 2.
Pilot Study of The EPIC Trial
ClinicalTrials.gov study NCT02533206. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Extended Pessary Interval for Care (EPIC Study)
ClinicalTrials.gov study NCT01644214. IPD Sharing: Not stated. Countries: 1. Publications: 16.
US Eeva™ Pregnancy Investigational Clinical Study (US EPIC)
ClinicalTrials.gov study NCT01671657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
ClinicalTrials.gov study NCT04611516. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
ClinicalTrials.gov study NCT01339702. IPD Sharing: Not stated. Countries: 1. Publications: 5.
EPIC-P Intervention
ClinicalTrials.gov study NCT04193787. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC)
ClinicalTrials.gov study NCT01737814. IPD Sharing: Not stated. Countries: 11. Publications: 1.
Epic Allies HIV ART Adherence Intervention
ClinicalTrials.gov study NCT02782130. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Development of novel, Exon-Primed Intron-Crossing (EPIC) markers from EST databases and evaluation of their phylogenetic utility in Commiphora (Burseraceae)
Open the record for dataset details and reuse information.
Implementation of a learning healthcare system for Sickle Cell disease: List of smart data elements contained in the Epic Smartform and their SmartData types
Open the record for dataset details and reuse information.
DSCOVR EPIC Level 2 Total Ozone, Version 3
DSCOVR_EPIC_L2_TO3_v03 is Level2 Total Ozone derived from the Deep Space Climate Observatory (DSCOVR) Earth Polychromatic Imaging Camera (EPIC) using Level 1b version 3 inputs and version 3 ozone retrieval algorithm. The measurements from four EPIC UV (ultraviolet) channels derive the global distributions of total ozone over the entire sunlit portion of the Earth. A new soft calibration technique developed based on scene matching with OMPS gives calibrated EPIC radiances. The calibrated EPIC radiances derive science-quality total ozone products from EPIC consistent with those from other UV instruments. The retrieval algorithm uses wavelength triplets and assumes that the scene reflectivity changes linearly with wavelength. Version 3 algorithm includes several key modifications aimed to improve total ozone retrievals: a) switch to Version 3 Level 1b product with improved geolocation registration, flat field, and dark counts corrections; b) replace OMI-based (Ozone Monitoring Instrument) cloud height climatology with the simultaneous EPIC A-Band cloud height; c) update absolute calibrations using polar orbiting the NASA OMPS SNPP ( Ozone Mapping and Profiler Suite / Suomi National Polar-orbiting Partnership Ozone); d) add corrections for ozone profile shape and temperature; e) update algorithm and error flags to filter data; f) add column weighting functions for each observation to facilitate error analysis. EPIC ozone retrievals accurately capture short-term synoptic changes in total column ozone. With EPIC measurements from DSCOVR's vantage point, synoptic ozone maps can be derived every 1-2 hours. Scene Reflectivity (clouds, aerosols, and surface) is derived from ozone retrieval. In conjunction with ozone, the scene reflectivity has been used to derive the amount of UV solar radiation reaching the ground, and surface UV Erythemal is also reported in these files.
External validation of EPIC's Risk of Unplanned Readmission model, the LACE+ index and SQLape® as predictors of unplanned hospital readmissions: A monocentric, retrospective, diagnostic cohort study in Switzerland
<p>Introduction: Readmissions after an acute care hospitalization are relatively common, costly to the health care system, and are associated with significant burden for patients. As one way to reduce costs and simultaneously improve quality of care, hospital readmissions receive increasing interest from policy makers. It is only relatively recently that strategies were developed with the specific aim of reducing unplanned readmissions using prediction models to identify patients at risk. EPIC's Risk of Unplanned Readmission model promises superior performance. However, it has only been validated for the US setting. Therefore, the main objective of this study is to externally validate the EPIC's Risk of Unplanned Readmission model and to compare it to the internationally, widely used LACE+ index, and the SQLAPE® tool, a Swiss national quality of care indicator.</p> <p>Methods: A monocentric, retrospective, diagnostic cohort study was conducted. The study included inpatients, who were discharged between the 1<sup>st</sup> of January 2018 and the 31<sup>st</sup> of December 2019 from the Lucerne Cantonal Hospital, a tertiary-care provider in Central Switzerland. The study endpoint was an unplanned 30-day readmission. Models were replicated using the original intercept and beta coefficients as reported. Otherwise, score generator provided by the developers were used. For external validation, discrimination of the scores under investigation were assessed by calculating the area under the receiver operating characteristics curves (AUC). Calibration was assessed with the Hosmer-Lemeshow <i>X</i><sup><i>2</i></sup><span><span></span></span> goodness-of-fit test This report adheres to the TRIPOD statement for reporting of prediction models.</p> <p>Results: At least 23,116 records were included. For discrimination, the EPIC´s prediction model, the LACE+ index and the SQLape® had AUCs of 0.692 (95% CI 0.676-0.708), 0.703 (95% CI 0.687-0.719) and 0.705 (95% CI 0.690-0.720). The Hosmer-Lemeshow <i>X</i><sup><i>2</i></sup><span><span></span></span> tests had values of p<0.001.</p> <p>Conclusion: In summary, the EPIC´s model showed less favorable performance than its comparators. It may be assumed with caution that the EPIC´s model complexity has hampered its wide generalizability - model updating is warranted.</p>
M-values from Illumina EPIC BeadChip DNA methylation analyses on DNA in whole blood for children exposed to PFAS
<p>Perfluoroalkyl substances (PFASs) are widespread synthetic substances with various adverse health effects. A potential mechanism of toxicity for PFASs is via epigenetic changes, such as DNA methylation. In this exploratory study with school-age children exposed to PFASs through drinking water highly contaminated from firefighting foams, we aimed to investigate whether exposure to PFASs was associated with alteration in DNA methylation and epigenetic age acceleration. Sixty-three children aged 7–11 years from the Ronneby Biomarker Cohort (Sweden) were included. The children were either controls with only background exposure (n=32; perfluorooctane sulfonic acid: median 2.8 and range AQ11 1–5ng/ml) or those exposed to very high levels of PFASs (n=31; perfluorooctane sulfonic acid: median 295 and range 190–464ng/ml). These two groups were matched on sex, age, and body mass index. Genome-wide methylation of whole-blood DNA was analyzed using the Infinium MethylationEPIC BeadChip kit.</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.